Wall Street ends slightly higher, boosted by industrials while the healthcare sector collapses
US markets closed on a cautious yet positive note Thursday, with the S&P 500 gaining 0.58% and the Dow Jones increasing by 0.31%. However, this apparent calmness hides significant underlying shifts, with dramatic divergences between sectors. While selective industrial and technology stocks are thriving, the healthcare insurance sector is undergoing a major crisis, highlighted by the collapse of Molina Healthcare. This session reflects the ongoing structural economic tensions in the United States, particularly in the healthcare sector where medical costs are skyrocketing, far exceeding the premiums collected by insurers.
Industrials soar, buoyed by better-than-expected results
The industrial sector is shining once again, led by a constellation of revitalized stocks. Dow Inc., the chemical giant, is leading daily gains with a spectacular increase of 12.95%, closing at $24.51. This surge comes after the company's quarterly results revealed a stronger-than-anticipated performance despite a gloomy macroeconomic backdrop. Dover Corporation follows with a more moderate rise of 8.12%, while Honeywell International gains 6.81%. These robust performances reflect a more resilient underlying demand in heavy industry and specialized equipment. Oil companies are also riding this wave, with Valero Energy climbing 6.96% after exceeding its third-quarter earnings estimates, driven by exceptional refining margins and a record refinery utilization rate of 97%. The energy sector is benefiting from the persistent strength in oil prices, with Brent crude trading at $76 per barrel. This revitalization of industrial stocks suggests that certain sectors are beginning to absorb inflationary pressures without sacrificing profit margins. However, this optimism doesn't erase broader concerns about the economic trajectory, particularly in light of geopolitical tensions and upcoming US elections.
The tech sector remains volatile, with clear winners and losers
Technology paints a nuanced picture at the end of October, with spectacular winners and notable collateral damage. Monolithic Power Systems surges 6.93% to $1,070.80, benefiting from the persistent demand for semiconductors in artificial intelligence. Other chipmakers also show respectable gains: KLA Corporation increases by 4.01%, while Lam Research and Teradyne advance 4.45% and 4.47%, respectively. Intuitive Surgical, the flagship of surgical robotics, appreciates by 4.61%. However, this positive momentum is heavily overshadowed by the debacle of Super Micro Computer, which falls 8.72%, closing at $47.92. The AI server manufacturer, once a market star with a 2,000% increase over two years, continues to suffer from allegations of accounting irregularities made by Hindenburg Research, compounded by the resignation of its auditor Ernst & Young in September. This gap between certain tech stocks and the collapse of Super Micro reflects a growing discrimination among investors, favoring companies with impeccable balance sheets and sustainable growth prospects over those tainted by regulatory doubts.
The Cataclysm in the Healthcare Sector: Molina Healthcare Drops 17.49%
The health insurance sector is experiencing a major upheaval, with Molina Healthcare plummeting by 17.49% to $161, marking the worst performance of the day within the S&P 500. This decline follows disastrous quarterly results that shocked Wall Street. The company reported adjusted earnings per share of only $1.84, far below the expected $3.89, a disappointing shortfall of 52.7%. The diagnosis is clear-cut: medical costs are spiraling out of control, particularly in the Affordable Care Act market segment, where the consolidated medical cost ratio has reached an alarming 92.6% compared to 89.2% a year earlier. For every dollar of premium received, Molina now spends more than 90 cents on medical care, an economically unsustainable situation. This increase is driven by much higher than anticipated utilization of healthcare services by insured individuals, especially in long-term care, costly drugs including GLP-1s, and behavioral health services. The management's response has been severe: they have revised down the 2025 annual guidance by 26.3% to approximately $14 per share instead of previous forecasts. This debacle is causing an immediate contagion effect, with Centene Corporation dropping by 4.61%, and UnitedHealth, Humana, and Elevance Health also coming under pressure. The market is anxiously considering whether the entire health insurance sector has entered a lasting structural crisis, fueled by runaway medical inflation that premiums can no longer keep pace with.
This content has been automatically translated using artificial intelligence. While we strive for accuracy, some nuances may differ from the original French version.
